Bharat Biotech Controversy - Search Videos

With no efficacy data available, is the Bharat Biotech vaccine against the coronavirus safe and effective? The Serum Institute of India vaccine will be the main drug, AIIMS Director Dr Randeep Guleria told NDTV, adding that the Bharat Biotech vaccine will only be used as a backup. | NDTV

With no efficacy data available, is the Bharat Biotech vaccine against the coronavirus safe and effective? The Serum Institute of India vaccine will be the main drug, AIIMS Director Dr Randeep Guleria told NDTV, adding that the Bharat Biotech vaccine will only be used as a backup. | NDTV

50.3K viewsJan 2, 2021

'Not scientifically designed': Bharat Biotech rejects study that claimed Covaxin less effective than Covishield

'Not scientifically designed': Bharat Biotech rejects study that claimed Covaxin less effective than Covishield

Vaccine Nationalism: Bharat Biotech Hits Out At Detractors |

Vaccine Nationalism: Bharat Biotech Hits Out At Detractors |

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech’s consent forms 'must' for Covaxin shot: What does the form say? https://bit.ly/39BcXdA | The Economic Times

Bharat Biotech’s consent forms 'must' for Covaxin shot: What does the form say? https://bit.ly/39BcXdA | The Economic Times

9.4K viewsJan 16, 2021

FacebookThe Economic Times

'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row

'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row

COVID-19: Bharat Biotech confirms adverse event during vaccine trial

COVID-19: Bharat Biotech confirms adverse event during vaccine trial

"Don't Accuse Us Of Inexperience, We Are Global Company": Bharat Biotech |

‘Wrong to Say We Are Not Transparent in Data,’ Says Bharat Biotech Chief on Row Over COVAXIN

Bharat Biotech ने भ्रष्टाचार के आरोप के बाद ब्राज़ील की 2 कंपनियों के साथ समझौता रद्द किया

Bharat Biotech Terminates MoU With Brazilian Partners After Controversy Over Covaxin Deal

‘I’m from farmer family...’: Vaccine-maker Bharat Biotech’s MD on controversy

Hindustan TimesHT Correspondent

Bharat Biotech's Vaccine Cleared By Expert Panel

NDTVSonal Mehrotra

Vaccine Nationalism: Bharat Biotech Slams Critics

Hyderabad-based Bharat Biotech is working on developing what could be a nasal vaccine to fight the coronavirus pandemic. This vaccine, when ready, will be delivered intranasally. NDTV's Uma Sudhir spoke with Bharat Biotech Joint Managing Director Suchitra Ella. | NDTV

46.1K viewsApr 28, 2020

Bharat Biotech announces interim analysis results of Phase3 trials Track latest news updates https://bit.ly/2Qo1kkm | The Economic Times

14.7K viewsApr 21, 2021

FacebookThe Economic Times

Indian state rejects Bharat Biotech vaccine approved without efficacy data

timeslive.co.za

Bharat Biotech & SII issue joint statement; pledge global access to COVID-19 vaccines Watch more on Republic World ► http://bit.ly/2QoRSt0 | Republic

13.4K viewsJan 5, 2021

FacebookRepublic

India’s Bharat Biotech applies for emergency use authorization in PH for its COVID-19 vaccine | ABS-CBN News

Did Bharat Biotech's response on Covaxin controversy settle the wrangle? | The Urban Debate

timesnownews.com

Covaxin booster shot neutralises Omicron, says Bharat Biotech

Bharat Biotech explains COVAXIN's 'vaccine to vaccination' process; says it takes 120 days Watch more on Republic World ► http://bit.ly/2QoRSt0 | Republic

76.4K viewsMay 28, 2021

FacebookRepublic

India’s Bharat Biotech Says Vaccine Is Effective Against Delta Variant

Trial nod has been given to Bharat Biotech to conduct phase-3 trials for intranasal vaccine: Sources @Runjhunsharmas shares more details with @JamwalNews18 | News18

20.3M viewsJan 5, 2022

A letter by the ICMR asked the company to launch Covaxin by August 15. Bharat Biotech has been asked to accelerate its trails as well and to adhere to the timelines. even DCGI has cleared 'Covaxin' trails. | News18

10.4K viewsJul 4, 2020

Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin |

Bharat Biotech terminates agreement with Brazilian partners after graft allegations

Expert panel approves Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds

Inactivated vaccines safest with lesser adverse reactions: Bharat Biotech

Bharat Biotech makes big announcement, reveals who should avoid COVID-19 vaccine

See more